This document discusses acute rheumatic fever, which can develop as a complication of untreated streptococcal infections like strep throat. It is caused by Streptococcus pyogenes bacteria. The document covers the classification, morphology, culture characteristics and pathogenesis of S. pyogenes. It also discusses the signs and symptoms of acute rheumatic fever, laboratory diagnosis including antigen and antibody tests, and imaging studies used to diagnose rheumatic heart disease. Rheumatic fever remains an important cause of acquired heart disease in developing countries.
It discusses laboratory tests involved in diagnosing meningitis with more emphasis on details of each test and findings, esp useful for microbiologists and medical students.
It discusses laboratory tests involved in diagnosing meningitis with more emphasis on details of each test and findings, esp useful for microbiologists and medical students.
Multipex for viral and atypical pneumoniaPathKind Labs
Diagnosis of pneumonia can be challeging, especially if pathogens other than Streptococcus pneumoniae are involved Multiplex PCR with results available within the same day can investigate the presence or absence of 16 viruses and 5 bacteria, enablng the physician to make informed decisions about treatment, prognosis and public health and infection control measures.
Diagnosis and Management of Acute Community Acquired Pneumonia - Professor Iv...WAidid
How do we diagnose acute CAP? What are the ways to treat patients with CAP? Professor Ivan Hung (Hong Kong) presents his answers in his 2015 Pneumonia Lectures.
Learn more on www.waidid.org
Pulmonary/Thoracic Sarcoidosis by Dr. Malik Umer Farooq
What is pulmonary sarcoidosis? Sarcoidosis is a rare disease caused by inflammation. It usually occurs in the lungs and lymph nodes, but it can occur in almost any organ. Sarcoidosis in the lungs is called pulmonary sarcoidosis. It causes small lumps of inflammatory cells in the lungs.
Multipex for viral and atypical pneumoniaPathKind Labs
Diagnosis of pneumonia can be challeging, especially if pathogens other than Streptococcus pneumoniae are involved Multiplex PCR with results available within the same day can investigate the presence or absence of 16 viruses and 5 bacteria, enablng the physician to make informed decisions about treatment, prognosis and public health and infection control measures.
Diagnosis and Management of Acute Community Acquired Pneumonia - Professor Iv...WAidid
How do we diagnose acute CAP? What are the ways to treat patients with CAP? Professor Ivan Hung (Hong Kong) presents his answers in his 2015 Pneumonia Lectures.
Learn more on www.waidid.org
Pulmonary/Thoracic Sarcoidosis by Dr. Malik Umer Farooq
What is pulmonary sarcoidosis? Sarcoidosis is a rare disease caused by inflammation. It usually occurs in the lungs and lymph nodes, but it can occur in almost any organ. Sarcoidosis in the lungs is called pulmonary sarcoidosis. It causes small lumps of inflammatory cells in the lungs.
updated info from reliable source .
it helps in understanding complications due to covid . it is handy for interns and postgraduates to act when cases come ,
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
3. INTRODUCTION
•RHEUMATIC FEVER
Rheumatic fever is an inflammatory disease that
can develop as a complication of inadequately
treated streptococcal sore throat or scarlet fever
which can lead to RHEUMATIC HEART
DISEASE.
4. CAUSES
Streptococcus pyogens (β-hemolytic streptococcus)
- They Exhibit a wide zone (2-4 mm wide) of complete
haemolysis with the presence of enzyme Streptolysin.
(RBC)
11. CULTURAL CHARACTERISTICS
They are aerobic and
facultative anaerobes.
They grow best at 37˚ Celsius
Growth is poor on solid media or broth
Grow well in media containing blood and sugar and 10%
CO2 in environment promotes growth and hemolysis
15. Mode of transmission –inhalation/ingestion of bacteria
Entry of bacteria
Pharyngitis by Group A β-hemolytic streptococcus
M1 protein of streptococcus pyogens is released in blood circulation
97 % pharyngitis is cured ,but ~3 % there is development of
antibodies against M1 protein by host immune system
M1 protein has molecular similarity with glycoprotein antigen of
human cell membrane thus antibodies cross react with them and
affect heart ,joints and brain
RHEUMATIC FEVER
Recurrent of bacteria and reactivation of immune system
Progressive damage
16. Clinical symptoms
-Primarily acute infections of respiratory tract and
skin are seen.
-Sore throat (acute tonsilitis and/or pharyngitis) is
most common.
22. SPECIMEN
-Collected from the site of lesion such as:-
1.Swab
2.Pus
3. Blood
-Collection of specimen depends on the nature of
infection such as swab taken from throat , vagina or
purulent lesion of patients and throat and nose of
suspected carriers.
23. MICROSCOPY
The information may be obtained by an examination of
gram stain film from pus.
The presence of gram positive cocci in chain is indicative of
streptococcal infection .
24. CULTURE
Specimen:
- SPIKE’S TRANSPORT MEDIUM (Blood agar
containing 1 in 1,000,000 crystal violet and 1 in
16000 sodium azide.)
- Blood agar medium and incubated at 37 C for
overnight .
Haemolysis develops better under anaerobic condition or
under 5-10 % CO2 .
Sheep blood agar is preferable as human blood may
contain inhibitors.
The bacterial colonies are small typically dry and
surrounded by beta haemolysis .
25. Serological test:-
1. ANTIBODY TITRE TEST
2. ELISA
3. AGGLUTINATION TEST
4. ERYTHROCYTE SEDIMENTATION
RATE (ESR)
5. C-REACTIVE PROTEIN LEVEL
6. HEART REACTIVE ANTIBODY
7. RAPID DETECTION FOR B CELL
MARKER
26. ANTISTREPTOLYSIN O TEST
It is used to detect streptococcal antibodies directed against
streptococcal lysin O .
ASO test is done by serological methods like LATEX
AGGLUTINATION OR SLIDE AGGLUTINATION.
27. PROCEDURE
1.Bring all reagents and specimens to room temperature.
2.Place one drop (50 µl) of the positive control and 50 µl of the patient
serum into separate circles on the glass slide.
3.Shake the ASO latex reagent gently and add one drop (45 µl) on each
circle next to the sample to be tested and controlled.
4.Mix well using disposable stirrer spreading the mixture over the whole
test area and tilt the slide gently. Agitate for about 2 minutes with rotator
or by hand and observe for the presence or abscence of agglutination...
28. RESULT AND INTERPRETATION
Negative result:
No agglutination of the latex particles suspension
within two minutes.
Positive result:
An agglutination of the latex particles suspension will
occur within two minutes, indicating an ASO level of
more than 200 IU/ml.
29. ACUTE PHASE REACTANT , ERTHROCYTE
SEDEMENTATION RATE AND C-REACTIVE
PROTEIN
They are usually elevated at the onset of ARF and serve as
a manifestation in the Jones criteria.
These test are non specific but they maybe useful in
monitoring disease activity.
31. RAPID DETECTION FOR B CELL MARKER
This immunofluorescence technique for identifying the B-
cell marker D8/17 is positive in 90% of patients with
rheumatic fever and may be useful for identifying patients
who are at risk of developing rheumatic fever
32. Imaging Studies
A. Chest radiography
Chest radiography can reveal cardiomegaly and CHF in
patient with carditis
33. • B. ELECTROCARDIOGRAM (ECG)
ECG may demonstrate valvular regurgitant lesions
in patient with ARF who do not have clinical
manifestation of carditis.
34. CONCLUSION
RHEUMATIC FEVER is still the most common cause of
acquired heart disease in many developing countries.
The precise pathogenetic mechanism have never been
properly defined.
However it has been hypothesized that on exposure to
group A streptococci during infection ANTIGENIC
MIMICRY leads to autoimmune like reaction within the
human host and results in valvulitis , ultimately leading to
rheumatic valvular heart disease.